3 Australian Growth Stocks With Earnings Growth Over 23%

Australian inflation recently hit 4%, and interest rates moved to 4.60%. Cash in the bank now feels safer but also risks falling behind businesses that analysts expect to grow their earnings strongly over the next few years. This article focuses on a group of financially sound Australian growth hopefuls and highlights three stocks from that pool so you can judge whether they deserve a place on your watchlist.

The three stocks highlighted next are just a starting sample from this theme, and the full screen surfaced 90 more companies that analysts also expect to deliver strong earnings growth while keeping their balance sheets in reasonable shape. If you want to move quickly from ideas to a focused watchlist, head straight into the Healthy high growth potential screener to identify, filter, and analyze the candidates that best fit your own risk and return preferences.

Ora Banda Mining (ASX:OBM)

Ora Banda Mining runs the Davyhurst Gold Project in Western Australia, taking gold from exploration through to mining and sale. This is the key reason it fits the Healthy high growth potential theme. The miner generated about A$807 million from gold production and exploration, all in Australia, and has a market value near A$2.85b.

Ora Banda Mining ties directly into the Healthy high growth potential idea through Davyhurst, where current A$807.5 million in sales, a 26.8% profit margin and a 40.3% ROE sit alongside analyst forecasts for earnings expansion. The appeal hinges on how one pressure point shapes those margins over time.

That pressure point is exactly why the 4 key rewards and 1 important warning sign could be worth your time, especially if you want to see what might shift those margins next.

4DMedical (ASX:4DX)

4DMedical focuses on non invasive lung imaging and analytics that fit squarely with the Healthy high growth potential screener, generating about A$7.1 million from medical technology R & D of lung function analysis and carrying a market value of roughly A$2.6b.

4DMedical taps into rising demand for precise lung diagnostics and trial imaging, so the way it turns that interest into commercial traction is what really matters here.

"Partnership with Philips promised a $10Million USD minimum order commitment contract over the next 2 years starting December 2025, (over 2026 and 2027) Philips has added 4DMedicals CT:VQ technology as an official product on their catalog in North America."

Much now hinges on how that early momentum feeds through to broader adoption and whether one pressure point lets the expected earnings ramp fully play out.

That pressure point is exactly where the full narrative for 4DMedical shows whether 4DMedical’s momentum could accelerate, stall, or be quietly masking a very different risk profile.

Netwealth Group (ASX:NWL)

Netwealth Group runs a wealth platform that powers superannuation, managed accounts, and portfolio services, putting it squarely in the Healthy high growth potential theme as earnings-linked platform fees from advisers, SMSFs, and retail clients build on A$389.7 million in platform operations revenue and about A$4.2b market value.

For Netwealth Group, the real interest in this screener is how a growing, fee-based platform business can turn adviser flows and better technology into compounding earnings rather than just headline revenue.

"Netwealth's continued investment in best-in-class digital experience, platform functionality, and data analytics aligns with the ongoing digitisation of financial services and increasing regulatory focus on transparency, in turn positioning the company to capture greater adviser and client net inflows, bolster revenue growth, and strengthen platform stickiness."

What happens to that earnings path depends heavily on how one quiet pressure on profitability and cash generation ultimately resolves.

If that pressure on profitability has your attention, the full narrative for Netwealth Group explains how Netwealth Group’s earnings engine could either accelerate or stall from this point.

Seeking Alternatives Before The Crowd Moves

Fresh ideas tend to move first, and the strongest themes often break out while most investors are still watching. Do not get caught flat footed. Consider acting early to build your watchlist.

• Spot potential momentum leaders in traditional finance and digital assets by scanning the 18 cryptocurrency and blockchain stocks before the crowd wakes up to their story.
• Track established cash generators with staying power using the curated 3 dividend fortresses while current yields remain available.
• Hunt for potential future core holdings among the curated list of solid balance sheet and fundamentals (12 results) before stronger results attract a wider following and limit available choices.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com